US Broker Ratings

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 45.63% Potential Upside

For investors keen on the healthcare sector, Alignment Healthcare, Inc. (NASDAQ: ALHC) offers an intriguing opportunity with a significant potential upside of 45.63%. This California-based company..

Immunovant, Inc. (IMVT) Stock Analysis: Unpacking a 64.5% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should take a closer look at Immunovant, Inc. (NASDAQ: IMVT), a promising player in the burgeoning field..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with a 27.89% Potential Upside

Belite Bio, Inc (BLTE), a dynamic player in the biotechnology sector, stands out as a promising investment opportunity, particularly for those interested in the cutting-edge field..

NovoCure Limited (NVCR) Stock Analysis: Exploring a Potential 109% Upside with Innovative Cancer Treatment Solutions

NovoCure Limited (NASDAQ: NVCR), a pioneering force in the medical device sector, is captivating investor attention with its innovative tumor treating fields (TTFields) technology. This Switzerland-based..

Addus HomeCare Corporation (ADUS) Stock Analysis: Unveiling a 38.92% Potential Upside Opportunity

Investors seeking opportunities in the healthcare sector should take a closer look at Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the medical care facilities..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Discover a 52.45% Potential Upside with Robust Revenue Growth

LifeStance Health Group, Inc. (NASDAQ: LFST) is setting a distinct tone in the healthcare sector, particularly within the medical care facilities industry, with its innovative approach..

LivaNova PLC (LIVN) Stock Analysis: Potential 30% Upside Amid Strong Buy Ratings

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its robust 30.08% potential..

Privia Health Group, Inc. (PRVA) Investor Outlook: A Promising 45% Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector, particularly within the health information services industry. With a market capitalization of $2.72..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Analyst Consensus Points to a Promising 42.66% Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology company specializing in neuroscience, has captured investor attention with its robust pipeline and impressive analyst ratings. As a..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a 129% Potential Upside in the Healthcare Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is attracting significant attention within the healthcare sector, particularly among those invested in the dynamic world of biotechnology. With a market..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech Gem with a 45.92% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out as a compelling investment opportunity within the biotechnology sector, attracting attention with its robust growth prospects and significant potential..

Envista Holdings Corporation (NVST): Investor Outlook on a 13.76% Potential Upside

Envista Holdings Corporation (NYSE: NVST) stands out in the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $4.11 billion,..

Viking Therapeutics, Inc. (VKTX)

⚠️ No article content returned.

..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech Contender with 42.60% Upside Potential

MoonLake Immunotherapeutics, trading under the stock symbol MLTX, is emerging as a notable player in the biotechnology industry. Headquartered in Zug, Switzerland, this clinical-stage biotech company..

Sotera Health Company (SHC) Stock Analysis: Unpacking a 52.91% Potential Upside for Investors

Sotera Health Company (NASDAQ: SHC) stands as a compelling opportunity in the healthcare sector, particularly for investors seeking growth in the Diagnostics & Research industry. With..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Key Insights into Its 26.68% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a significant player in the biotechnology sector, with a market capitalization of $7.23 billion. Specializing in genetic medicines..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Unlocking an 81.82% Potential Upside in the Biotech Sector

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing the attention of investors with its innovative approach to RNA-based therapies, particularly targeting cardiomyopathies. The company specializes in developing..

Integer Holdings Corporation (ITGR): Investor Outlook and Potential 12.38% Upside

Integer Holdings Corporation (NYSE: ITGR) stands as a noteworthy player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $2.91..

Oscar Health, Inc. (OSCR) Stock Analysis: A 16.40% Potential Upside Amidst Revenue Growth

For investors navigating the labyrinth of healthcare stocks, Oscar Health, Inc. (NYSE: OSCR) presents a compelling, albeit complex, opportunity. With a market capitalization of $3.94 billion,..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 15% Upside as Healthcare Innovations Lead

Bausch + Lomb Corporation (NYSE: BLCO) stands out in the healthcare sector as a venerable player within the medical instruments and supplies industry. With a rich..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds